Missing eTable

No authors listed

Published Erratum

No authors listed. JAMA Oncol. 2019.

. 2019 Nov 1;5(11):1643.

doi: 10.1001/jamaoncol.2019.5486.

No abstract available

Erratum for

Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer: A Phase 1b/2 Pilot Clinical Trial.
Jameson GS, Borazanci E, Babiker HM, Poplin E, Niewiarowska AA, Gordon MS, Barrett MT, Rosenthal A, Stoll-D'Astice A, Crowley J, Shemanski L, Korn RL, Ansaldo K, Lebron L, Ramanathan RK, Von Hoff DD. Jameson GS, et al. JAMA Oncol. 2020 Jan 1;6(1):125-132. doi: 10.1001/jamaoncol.2019.3394. JAMA Oncol. 2020. PMID: 31580386 Free PMC article.

1. Jameson GS, Borazanci E, Babiker HM. Response rate following albumin-bound paclitaxel plus gemcitabine plus cisplatin treatment among patients with advanced pancreatic cancer: a phase 1b/2 pilot clinical trial [published online October 3, 2019]. JAMA Oncol. doi:10.1001/jamaoncol.2019.3394 - DOI - PMC - PubMed